FDA Approves Third Dose for Pfizer and Moderna COVID-19 Vaccines
Tuesday, 17 September 2024, 03:33
The FDA has officially approved a third dose of both the Pfizer and Moderna COVID-19 vaccines, a pivotal step towards strengthening immune response in the face of emerging variants.
This decision was supported by the CDC, which emphasizes the necessity of enhanced protection for public health safety.
Healthcare professionals are now focused on ensuring that the general population is aware of the availability of this additional dose and the ongoing need for vaccine uptake.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.